JDI is validating SR-82 from POSC/MIT right now. After validation, the generator will be ready for sale in Canada. The clinics will need generators and follow up replacements for their scans. Because the generator is approved already, they may not be just limited for use in the study. I think these clinics will continue to purchase the generators on a regular basis throughout the study and beyond. Why do you think sales to JDI is more than 6 months away?
In my original post, I mentioned the European Medicines Agency had issued waivers and deferrals for the Ruby-Fill generator for the study in Europe. Why wasn't Ruby-fill selling previously in Canada? They had no SR-82 supply.
Market Data 
Markets 
AI
